The latest price target for Cingulate (NASDAQ:CING) was reported by HC Wainwright & Co. on January 30, 2025. The analyst firm set a price target for $20.00 expecting CING to rise to within 12 months (a possible 345.43% upside). 3 analyst firms have reported ratings in the last year.

The latest analyst rating for Cingulate (NASDAQ:CING) was provided by HC Wainwright & Co., and Cingulate maintained their buy rating.

The last upgrade for Cingulate Inc happened on November 20, 2024 when Maxim Group raised their price target to N/A. Maxim Group previously had a hold for Cingulate Inc.

The last downgrade for Cingulate Inc happened on December 22, 2023 when Laidlaw & Co. changed their price target from N/A to N/A for Cingulate Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cingulate, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cingulate was filed on January 30, 2025 so you should expect the next rating to be made available sometime around January 30, 2026.

While ratings are subjective and will change, the latest Cingulate (CING) rating was a maintained with a price target of $8.00 to $20.00. The current price Cingulate (CING) is trading at is $4.49, which is out of the analyst’s predicted range.